Cardinal Health (NYSE:CAH) Issues FY 2027 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY 2027 earnings guidance on Tuesday morning. The company provided EPS guidance of 12.400-12.600 for the period, compared to the consensus earnings per share estimate of 12.050. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

Several analysts recently commented on CAH shares. Robert W. Baird set a $248.00 price objective on Cardinal Health in a report on Friday, May 1st. William Blair initiated coverage on Cardinal Health in a report on Tuesday, April 28th. They set an “outperform” rating for the company. UBS Group upped their price target on Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Wells Fargo & Company decreased their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Finally, Morgan Stanley lifted their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a report on Tuesday, April 28th. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $251.73.

Cardinal Health Price Performance

NYSE:CAH opened at $236.77 on Tuesday. The business has a 50 day simple moving average of $227.47 and a 200-day simple moving average of $216.44. The firm has a market capitalization of $55.45 billion, a price-to-earnings ratio of 36.20, a PEG ratio of 1.16 and a beta of 0.49. Cardinal Health has a 1 year low of $137.75 and a 1 year high of $244.87.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, analysts expect that Cardinal Health will post 10.77 earnings per share for the current fiscal year.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Strong earnings beat: Fourth-quarter non-GAAP EPS was $2.91, $0.49 above analyst expectations. Reported non-GAAP EPS increased 40% year over year, while GAAP operating earnings and diluted EPS each rose 70%. Cardinal Health EPS and revenue results
• Positive Sentiment: Above-target fiscal 2027 outlook: Cardinal Health forecast fiscal 2027 non-GAAP EPS of $12.40 to $12.60, representing 13% to 15% growth and exceeding the company’s long-term earnings-growth target. Cardinal Health fiscal 2027 outlook
• Positive Sentiment: Capital returns remain substantial: The company completed $1.4 billion of fiscal 2026 share repurchases, received authorization for an additional $5 billion buyback, and declared a quarterly dividend of $0.5158 per share, payable October 15. Cardinal Health fiscal 2026 results and guidance
• Neutral Sentiment: Financing update: Cardinal Health terminated a five-year revolving credit facility and restructured elements of its credit facilities and financing programs. The change may improve financing flexibility, although the immediate earnings impact is unclear. Cardinal Health credit facilities restructuring
• Negative Sentiment: Revenue missed expectations: Quarterly revenue rose 6% to $63.7 billion but fell approximately $1.4 billion short of consensus estimates near $65.1 billion. With a net margin of only 0.62%, the revenue shortfall and thin profitability remain risks, particularly with CAH trading at a relatively elevated P/E ratio.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CAH. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Cardinal Health in the 4th quarter valued at about $26,000. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares in the last quarter. Bank of Jackson Hole Trust purchased a new position in Cardinal Health during the fourth quarter valued at approximately $27,000. Turning Point Benefit Group Inc. purchased a new position in Cardinal Health during the third quarter valued at approximately $31,000. Finally, JPL Wealth Management LLC bought a new position in Cardinal Health in the third quarter worth approximately $31,000. 87.17% of the stock is currently owned by institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.